| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.16 | 0.4 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.4 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |